July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Extending far and wide: The role of biopsy and staging in the management of ocular surface squamous neoplasia (OSSN)
Author Affiliations & Notes
  • Christine Greer
    Ophthalmology, University of Southern California Roski Eye Institute, Pasadena, California, United States
  • Ashly A Polski
    Ophthalmology, University of Southern California Roski Eye Institute, Pasadena, California, United States
  • Jesse L Berry
    Ophthalmology, University of Southern California Roski Eye Institute, Pasadena, California, United States
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5598. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christine Greer, Ashly A Polski, Jesse L Berry; Extending far and wide: The role of biopsy and staging in the management of ocular surface squamous neoplasia (OSSN). Invest. Ophthalmol. Vis. Sci. 2018;59(9):5598.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To elucidate the role of biopsy and histologic grade on patient outcomes for ocular surface squamous neoplasia (OSSN) with involvement of multiple ocular structures (clinically stage T3).

Methods : A Retrospective chart review of patients undergoing treatment for OSSN at the USC Roski Eye Institute for OSSN identified 27 cases demonstrating clinical involvement of multiple ocular structures without orbital invasion. Tumor characteristics were evaluated by slit lamp photography and AS-OCT images. Size, and location were documented. Lesions involving any of adjacent structures were considered stage T3, according to the definitions provided by the AJCC, 7th edition. Primary surgical versus topical chemotherapy treatment was determined by the ocular oncologists. Biopsy was done in 17 patients. Histologic grade, treatment modality, time to cure, disease recurrence and/or persistence were documented for each neoplasm.

Results : Of the 27 cases 12 were treated primarily with surgery and 5 with chemotherapy. Among the 17 biopsied tumors, 11 demonstrated invasion beyond the basement membrane, classified by the AJCC 8 Ed. as stage T3. The remaining six neoplasms were staged as Tis based on lack of basement membrane invasion despite diffuse clinical involvement. There was no significant difference in persistent disease or recurrence, or time to cure when T3 and Tis tumors that received the same initial treatment were compared (excised T3 versus excised Tis; medically-treated T3 versus medically-treated Tis; p > 0.5 for all comparisons).

Conclusions : Clinical diagnosis of stage T3 OSSN based on involvement of multiple sites as described in the AJCC 7th ed. criteria was not predictive of basement membrane invasion in our cohort of biopsied OSSN lesions. While biopsy is a requirement for grading based on AJCC 8th Ed there was no significant difference in time to cure, persistent disease or recurrence between stage T3 versus Tis. Thus, although the current staging guidelines require biopsy, we found that this did not significantly affect patient outcomes.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×